Laboratory of Cellular and Molecular Neurobiology of Parkinson's Disease, Research Center for Molecular Medicine and Chronic Diseases (CIMUS), Dept. of Morphological Sciences, IDIS, University of Santiago de Compostela, Santiago de Compostela, Spain; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Spain.
Laboratory of Molecular Neurobiology, Faculty of Biology, University of Barcelona, Barcelona, Spain; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Spain.
Brain Behav Immun. 2020 Jul;87:256-271. doi: 10.1016/j.bbi.2019.12.011. Epub 2019 Dec 19.
Overactivity of the angiotensin-type-1 receptor (AT1)/NADPH-oxidase axis enhances aging processes, neuroinflammation and neurodegeneration. The role of AT2 receptors in the above-mentioned AT1-related effects in the aged brain, particularly substantia nigra, was investigated in this study. In the nigra, we observed a progressive decrease in AT2 mRNA expression with aging, and AT2 deletion led to changes in spontaneous motor behavior, dopamine receptors, renin-angiotensin system, and pro-oxidative and pro-inflammatory markers similar to those observed in aged wild type (WT) mice. Both aged WT mice and young AT2 KO mice showed an increased AT1, decreased MAS receptor and increased angiotensinogen mRNA and/or protein expression, as well as upregulation of pro-oxidative and pro-inflammatory markers. In cultures of microglial cells, activation of AT2 receptors inhibited the LPS-induced increase in AT1 mRNA and protein expression and neuroinflammatory markers. Both in AT2 KO microglial cultures and microglia obtained from adult AT2 KO mice, an increase in AT1 mRNA expression was observed. In cultured dopaminergic neurons, AT2 activation down-regulated AT1 mRNA and protein, and dopaminergic neurons from adult AT2 KO mice showed upregulation of AT1 mRNA expression. Both in microglia and dopaminergic neurons the pathway AT2/nitric oxide/cyclic guanosine monophosphate mediates the regulation of the AT1 mRNA and protein expression through downregulation of the Sp1 transcription factor. MAS receptors are also involved in the regulation of AT1 mRNA and protein expression by AT2. The results suggest that an aging-related decrease in AT2 expression plays a major role in the aging-related AT1 overexpression and AT1-related pro-inflammatory pro-oxidative effects.
血管紧张素型 1 受体(AT1)/NADPH 氧化酶轴的过度活跃会加速衰老过程、神经炎症和神经退行性变。本研究旨在探讨 AT2 受体在上述与衰老大脑相关的 AT1 相关效应(特别是黑质)中的作用。在黑质中,我们观察到随着年龄的增长,AT2mRNA 表达逐渐下降,而 AT2 缺失导致自发性运动行为、多巴胺受体、肾素-血管紧张素系统以及促氧化和促炎标志物发生变化,这些变化类似于在老年野生型(WT)小鼠中观察到的变化。在 WT 老年小鼠和年轻 AT2KO 小鼠中,均观察到 AT1 增加、MAS 受体减少、血管紧张素原 mRNA 和/或蛋白表达增加,以及促氧化和促炎标志物的上调。在小胶质细胞培养物中,AT2 受体的激活抑制了 LPS 诱导的 AT1mRNA 和蛋白表达以及神经炎症标志物的增加。在 AT2KO 小胶质细胞培养物和成年 AT2KO 小鼠的小胶质细胞中,均观察到 AT1mRNA 表达增加。在培养的多巴胺能神经元中,AT2 激活下调了 AT1mRNA 和蛋白表达,并且来自成年 AT2KO 小鼠的多巴胺能神经元显示出 AT1mRNA 表达的上调。在小胶质细胞和多巴胺能神经元中,AT2/一氧化氮/环鸟苷单磷酸途径通过下调 Sp1 转录因子来介导 AT1mRNA 和蛋白表达的调节。MAS 受体也参与 AT2 对 AT1mRNA 和蛋白表达的调节。这些结果表明,与衰老相关的 AT2 表达减少在与衰老相关的 AT1 过表达和 AT1 相关的促炎促氧化效应中起着主要作用。